The Motley Fool

Integrated Research share price hits record high – should you invest?

The share price of software solutions provider Integrated Research Limited (ASX: IRI) reached an all-time high in early afternoon trade, surging over 5% to a new high of $4.40.

The Integrated Research share price got off to a hot start today after the company informed the market it would be releasing full-year earnings for FY19 on 20 August. The share price has, however, also been assisted by the collective gains of the ASX technology sector more broadly.

Today’s result means the company has more than doubled in value since bottoming out at $2.19 in March. But I think the Integrated Research share price still has some growth ahead of it, particularly over the medium to long term.

What’s driving the Integrated Research share price to an all-time high during this period of extreme volatility?

Impressive FY19 earnings

The Integrated Research share price has improved since the company, which is a leading global provider of management solutions for critical unified communications, payments, contact centres and IT infrastructure, provided a sneak-peak for expected FY19 profit guidance on 17 July.

This announcement indicated that revenue was expected to grow by around 9%-10% up to as much as $111 million. Likewise, profit after tax was touted to see an improvement of around 8%-11%.

Despite last month’s announcement being subject to the necessary financial auditing requirements, the Integrated Research share price has been bolstered by over 13% since these figures were revealed.

Why I think the Integrated Research share price is still a buy

Although we’ll know for sure just how well the company has performed in a couple of weeks, I like Integrated Research for its unique product offering, ‘Prognosis for Unified Communications (UC)’.

In last month’s profit guidance update, the company cited that its 13%-15% increase in licence sales was predominantly driven by its UC products.

Prognosis for UC is a performance management solution for voice, video and collaboration ecosystems, allowing its clients to monitor, troubleshoot, and optimise complex UC environments on-premises, in the cloud, or both.

Integrated Research offers the Prognosis suite in over 60 countries worldwide, and the company has benefitted from contracts with Avaya, Microsoft, Cisco, AT&T and Australia and New Zealand Banking Group Limited (ASX: ANZ) among others.  

I believe the growth of the company’s ‘Prognosis’ platform is a key factor currently driving the positive movements of its share price.

Foolish takeaway

With working from home protocols resulting in unprecedented demand for software as a service (SaaS) and enhanced capabilities in the cloud itself, I see companies such as Integrated Research continuing to perform well over the medium to long term.

This company remains a watchlist item for me at this point, but I’ll be keeping a close eye on its Prognosis UC platform over the coming months.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

*Returns as of June 30th

Toby Thomas has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Integrated Research Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Related Articles...

Latest posts by Toby Thomas (see all)